Clinical Trial

Animal-Assisted Therapy Combined With Standard Rehabilitation for Motor Recovery in Dementia Patients in a Medical and Rehabilitation Care Unit

Study acronym: RéMédi - A
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this randomized study is to find out if animal-assisted therapy (AAT) - a structured program where trained animals take part in care sessions guided by health professionals - can help improve movement abilities in older adults with dementia or memory-related conditions who are staying in a medical rehabilitation unit. The main questions this study aims to answer are: * Can adding animal-assisted therapy to standard rehabilitation improve participants' movement and motor abilities better than standard rehabilitation alone? * Can this combined approach help participants stay more independent in daily activities? * Can this combined approach improve participants' quality of life? * Can this combined approach reduce the risk of falls? Researchers will compare two groups: * Group 1 (experimental): Standard rehabilitation + animal-assisted therapy sessions with a trained dog and/or rabbits * Group 2 (control): Standard rehabilitation alone Both groups attend 2 one-hour rehabilitation sessions per week for 4 weeks. Participants will: * Complete movement and daily-life ability tests at the start and end of the study * Attend 8 rehabilitation sessions (over 4 weeks) * Participants in the animal therapy group will interact with a trained dog and/or rabbits during sessions, guided by a certified nurse-animal therapist, a psychomotor therapist, and a nursing assistant * Be assessed at the end of the 4-week program (Week 6) to measure any changes in motor abilities, independence, quality of life, and fall risk
Trial Details
NCT Number NCT07730983
Lead Sponsor LNA SANTE
Conditions Dementia, Cognitive Dysfunction ( MMSE < 24 ), Motor Skills Disorders
Enrollment 32 participants
Start Date 2026-09
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-28